Henning Kelbæk

Showing 1-20 of 28 articles

Coronary interventions

Myocardial Damage After ST-Segment Elevation Myocardial Infarction According to the Use of Bivalirudin or Heparin A Cardiac Magnetic Resonance Substudy of the DANAMI3 trial

Schoos MM, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Goransson C, Holmvang L, Kelbæk H, Helqvist S, Høfsten D, Køber L, Vejlstrup N, Lønborg J, Engstrøm T

December 17, 2019 | 10.4244/EIJ-D-19-00623

Coronary interventions

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F-J, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

November 20, 2019 | 10.4244/EIJ-D-19-00866

Coronary interventions

Fractional Flow Reserve Guided PCI in Patients With and Without Left Ventricular Hypertrophy: a DANAMI-3-PRIMULTI Sub-study

Sabbah M, Nepper-Christensen L, Lønborg J, Helqvist S, Køber L, Høfsten D, Ahtarovski K, Goransson C, Kyhl K, Schoos M, Vejlstrup N, Kelbæk H, Engstrøm T

November 20, 2019 | 10.4244/EIJ-D-19-00577

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted H, Raungaard B, Jørgensen E, Køber L, Høfsten D, Kelbæk H, Engstrøm T

June 20, 2019 | 10.4244/EIJ-D-18-00766

Coronary interventions

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

Kjoller-Hansen L, Bligaard N, Kelbæk H, Christiansen EH, Thuesen L, Hansen PR, Engstrøm T, Junker A, Abildgaard U, Flensted Lassen J, Jensen JS, Jeppesen JL, Galloe A

September 20, 2018 | 10.4244/EIJ-D-18-00396

STEMI

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

Nepper-Christensen L, Lønborg J, Hofsten D, Ahtarovski K, Kyhl K, Goransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T

August 24, 2018 | 10.4244/EIJ-D-17-00857

Coronary interventions

To defer, or not to defer, that is the question

Kelbæk H, Hofsten D, Engstrøm T

July 20, 2017 | 10.4244/EIJV13I4A58

Coronary interventions

Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Sadjadieh G, Engstrøm T, Helqvist S, Hofsten D, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L

November 20, 2016 | 10.4244/EIJV12I10A203

Coronary interventions

Acute myocardial infarction and lesion location in the left circumflex artery: importance of coronary artery dominance

Waziri H, Jørgensen E, Kelbæk H, Fosbøl E, Pedersen F, Mogensen U, Gerds T, Køber L, Wachtell K

July 20, 2016 | 10.4244/EIJY15M09_04

Coronary interventions

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Coronary interventions

Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis

De Backer O, Biasco L, Lønborg J, Pedersen F, Holmvang L, Kelbæk H, Arnous S, Saunamäki K, Helqvist S, Kastrup J, Jørgensen E, Engstrøm T

February 12, 2016 | 10.4244/EIJV11I11A247

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Holmvang L, Richardt G, Eberli F, Stella P, Buszman P, Neumann F-J, Serruys P, Windecker S, Widimsky P, Belardi J, Silber S

October 20, 2015 | 10.4244/EIJY14M07_14

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

Schoos M, Pedersen F, Holmvang L, Engstrøm T, Saunamäki K, Helqvist S, Kastrup J, Mehran R, Dangas G, Jørgensen E, Kelbæk H, Clemmensen P

September 22, 2015 | 10.4244/EIJY14M11_07

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

Taniwaki M, Stefanini G, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabaté M, Windecker S

August 20, 2015 | 10.4244/EIJY14M07_12

How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?

Martin-Yuste V, Alvarez-Contreras L, Sabaté M, Kelbæk H, Saunamäki K, Jørgensen E, Kočka V

February 20, 2015 | 10.4244/EIJV10I10A208

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen C

August 19, 2014 | 10.4244/EIJV10I4A80

Flow disturbances in stent-related coronary evaginations: a computational fluid-dynamic simulation study

Radu M, Pfenniger A, Räber L, de Marchi S, Obrist D, Kelbæk H, Windecker S, Serruys P, Vogel R

May 20, 2014 | 10.4244/EIJV10I1A18

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

Radu M, Räber L, Heo J, Gogas B, Jørgensen E, Kelbæk H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia H, Windecker S, Saunamäki K, Serruys P

January 20, 2014 | 10.4244/EIJV9I9A183

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K

July 26, 2013 | 10.4244/EIJV9I3A52

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study

Kelbæk H, Engstrøm T, Ahtarovski K, Lønborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamäki K, Jørgensen E, Clemmensen P, Kløvgaard L, Tilsted H, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Køber L

February 22, 2013 | 10.4244/EIJV8I10A175

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Paravalvular leak after TAVI & TAVI with ACURATE NEO

January 7, 2020

Henning Kelbæk

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke